Incidence and Long-Term Cost of Oral Steroid-Related Adverse Events in Chronic Diseases in Poland
Value Health
.
2014 Nov;17(7):A507-8.
doi: 10.1016/j.jval.2014.08.1550.
Epub 2014 Oct 26.
Authors
M Garbacka
1
,
A Zapalska
1
,
E Borowiack
1
,
D Tronczyñska
2
,
K Wepsiec
2
,
D Dziurda
2
,
A Krzyzanowska
2
Affiliations
1
NUEVO HTA CLP, Cracow, Poland.
2
GlaxoSmithKline, Warsaw, Poland.
PMID:
27201548
DOI:
10.1016/j.jval.2014.08.1550
No abstract available